Most physicians think research means an expensive CTMS, an on-site coordinator, and a separate research company. It doesn't. Celéri's platform absorbs the stack — turn it on, generate evidence, and join a network sponsors publish to. No research staff. No leaving clinical workflow. No waiting years for academic collaboration.
The barrier to research isn't capability — it's the assumption that it requires infrastructure you don't have. Here's what the platform replaces.
Enrollment, eConsent, PRO capture, data management, and a Part 11-ready audit trail — all in one governed environment. Nothing to license, nothing to integrate.
PRO assessments route themselves via SMS, email, or tablet at every milestone. A trained existing staff member manages exceptions — not a new full-time hire doing source-data verification.
Registries and investigator-initiated studies run under your own practice, with the consent architecture and central IRB Celéri arranges. A separate entity is an option at scale — never a prerequisite.
Research-as-a-practice-line is a graduation, not a leap. Most practices reach Tier 1 in weeks — with no hires and nothing to buy — and climb only as far as their goals require.
Flip on structured PRO and registry collection through PainIntel™. Every encounter becomes a longitudinal data point you own — searchable by diagnosis, procedure, payer, or outcome.
Add a pre-specified protocol, reconsent, and central IRB on the Part 11-ready platform. Your registry becomes a dataset that holds up to peer review, congress abstracts, and payer conversations.
Join the network MedTech and pharma sponsors publish to as candidate sites for feasibility. Hart Clinical provides GCP, monitoring, and regulatory surge — on demand, only when a study needs it.
Tiers 1–2 are genuinely plug-and-play. Tier 3 is where formal trial rigor enters — and even then, you draw on shared clin-ops rather than building it in-house.
Because we know pain, we know which PRO the literature validates for each intervention — the accepted instrument for that condition, procedure, and timepoint. Celéri encodes that expertise into a conditional Pain Pathway unique to your practice. Turn it on, and it runs in the background: the right, literature-fit assessment reaches the right patient at the right visit, automatically.
Configured once at kickoff. Runs automatically — delivered by SMS, email, or tablet with zero staff intervention. And because each instrument is the literature-fit choice, the same capture serves two masters at once: it's clinically useful at the point of care and credible in research and publication — no second data-collection pass, no compromise. Your pathway evolves as your practice does — add a procedure type, and its rules come with it.
PainIntel™ is the engine — everything else plugs into it. It captures the right PRO at the point of care; that data then flows into your EaaS™ program and accrues in the PainRWD™ Science Cloud. Here's the practice-facing stack.
The point-of-care PRO capture engine — it collects the literature-fit instrument at every encounter and structures it into the registry you own. Where the data is born.
Your custom appointment-type → PRO algorithm, configured for your practice at kickoff. The rules that make it run in the background.
The branded patient channel for check-ins and pain tracking between visits — lifting completion and long-term follow-through.
Where the evidence builds in real time: enrollment, PRO trajectories, and outcome signals, benchmarked to the network.
From your first PRO to your first publication — the platform, the protocol infrastructure, and the partner network, so you can focus on the science, not the administration.
Every encounter becomes structured data. PainIntel™ captures PROs automatically across your procedure types — a longitudinal registry you own.
Master IRB protocols and pre-specified study designs move you from concept to enrollment in weeks. IRB submission support through the Celéri Research Group.
PatientFinder™ identifies study and advanced-therapy candidates within your existing panel — matching on diagnosis, procedure history, and clinical criteria. Automated outreach included.
Part 11-ready audit trails, pre-specified PRO instruments, timestamped longitudinal data, and de-identification infrastructure — credible when you submit to NANS, ISMCS, or a journal.
Best-in-class CRO, biostatistics, EDC, regulatory, and medical-writing partners — scoped to your study. Contract only what you need; Celéri coordinates the rest.
See your evidence building in real time — enrollment, PRO trajectories, and outcome signals, benchmarked against Celéri's aggregate network data.
The infrastructure meets you where you are — a quality program, an investigator-initiated study, or a multicenter trial.
Celéri configures your Pain Pathway at kickoff — procedure types, workflows, and PRO instruments. EHR integration covered at no cost. Zero ongoing staff burden.
Every patient, encounter, and follow-up — captured automatically. Your longitudinal registry grows in the background while you practice. No paper forms, no coordinator.
When you're ready to go further, the Research Group helps you frame the study, select the right track — Practice Insights Registry™ or Regulatory-Grade Evidence Cohort™ — and stand up the partner team.
Medical writing, biostatistics, and IRB coordination through the Research Group. Your data was structured for publication from the start — so the infrastructure is already in place.
Both run on the same PainIntel™ platform your practice already uses — scoped differently by research objective and regulatory context. Together they are Tier 2 of the offering.
Observational, practice-level data collection that builds structured outcomes evidence directly from your practice — for quality improvement, payer conversations, congress abstracts, and investigator-initiated publications.
Pre-specified protocol, IRB oversight, a Part 11 data environment, and validated comparator logic — for data that needs to hold up to FDA, payer, and peer-review scrutiny, including investigator-initiated trials.
| Your goal | Recommended pathway | Key infrastructure | Time to first output |
|---|---|---|---|
| Gather patient-level PROs for medical decision-making | PainIntel™ Point of Care | PainIntel + Command Center | 4–6 weeks to deployment |
| Build outcomes data for payer or credentialing conversations | Practice Insights Registry™ · Quality | PainIntel + Command Center | 3–6 months of enrollment |
| Submit an abstract to NANS, ISMCS, ASRA, or ASPN | Practice Insights Registry™ · Publication | PainIntel + Medical Writing | 12–18 months of enrollment |
| Publish in a peer-reviewed journal | Regulatory-Grade Evidence Cohort™ · Publication | PainIntel + IRB + Biostatistics | 18–24 months from protocol |
| Join a sponsored multicenter registry (optional) | EaaS™ Sponsored Engagement | PainIntel + EaaS sponsor infrastructure | FMV; enrollment-based |
| Run an investigator-initiated trial | Regulatory-Grade Evidence Cohort™ · IIT | PainIntel + Research Group coordination | Varies by design and IRB |
Structured outcomes collection can create real economic value for the practice. Because it's subject to payer policy, we frame it conservatively.
CPT 96127. PRO assessments gathered through PainIntel™ may be reimbursable under CPT 96127 where medically necessary and consistent with payer policy — helping offset platform cost.
Sponsored participation. Practices that also participate in sponsored multicenter registries may receive fair-market-value compensation from the sponsoring organization.
Reimbursement depends on payer, plan, and medical necessity. Celéri does not provide coding or billing advice — confirm applicability with your own reimbursement specialist.
The Part 11 EDC and data environment are Celéri's own — purpose-built, not outsourced. Around that core, access best-in-class specialist partners scoped to your study, without the overhead of managing multiple vendor relationships. You contract only what you need.
Central IRB review and human-subjects oversight — coordinated by Celéri so studies activate fast, with consistent governance across sites.
On-demand clin-ops surge for Tier 3 — GCP, site management, monitoring, regulatory strategy, and biostatistics. Deep expertise in interventional pain and neuromodulation.
KOL positioning, scientific communication, and evidence-to-market narrative for clinicians building a research reputation.
No. PainIntel™ is designed to run without research staff. Configuration happens once at kickoff — Celéri builds your Pain Pathway based on your procedure types. From there, PRO assessments deliver automatically and data flows to your Command Center without staff intervention. For formal study activation, the Research Group provides coordination through its partner network.
For an abstract (NANS, ISMCS, ASRA), most practices have sufficient data within 12–18 months of consistent enrollment. For a peer-reviewed manuscript, 18–24 months is typical, depending on procedure volume and study question. For multicenter IITs, timelines depend on the lead investigator's design and IRB approval.
Yes. Moving from a quality program to a formal investigator-initiated study, the Research Group provides IRB submission support through Hart Clinical Consultants. Celéri also maintains master IRB protocols for certain designs that can significantly accelerate local review.
Yes, when applicable. Practices participating in sponsored multicenter registries coordinated through Celéri receive fair-market-value compensation, structured by the sponsoring organization. Your Practice Insights Registry™ data — collected as part of your standard PainIntel™ deployment — belongs to your practice and is not subject to any external compensation arrangement.
Yes — and Celéri covers integration costs. Supported systems include Epic, Cerner, Athena, eClinicalWorks, DrChrono, Meditech, Veradigm, and Modernizing Medicine. Integration depth is what makes your registry publication-ready, so Celéri treats it as a core part of the platform.
Whether you're beginning with a quality outcomes program or ready to design a formal investigator-initiated study — Celéri gives you the infrastructure to get there without leaving clinical practice.